Janux Therapeutics Inc (JANX)
47.51
+0.03
(+0.06%)
USD |
NASDAQ |
May 16, 16:00
47.49
-0.02
(-0.04%)
Pre-Market: 20:00
Janux Therapeutics 1 Year Total Returns (Daily): 312.1% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 16, 2024 | 312.1% |
| May 15, 2024 | 294.7% |
| May 14, 2024 | 275.8% |
| May 13, 2024 | 292.1% |
| May 10, 2024 | 253.0% |
| May 09, 2024 | 289.9% |
| May 08, 2024 | 303.9% |
| May 07, 2024 | 316.9% |
| May 06, 2024 | 321.6% |
| May 03, 2024 | 331.9% |
| May 02, 2024 | 320.1% |
| May 01, 2024 | 279.1% |
| April 30, 2024 | 272.1% |
| April 29, 2024 | 266.1% |
| April 26, 2024 | 224.4% |
| April 25, 2024 | 218.2% |
| April 24, 2024 | 220.5% |
| April 23, 2024 | 223.0% |
| April 22, 2024 | 217.2% |
| April 19, 2024 | 205.8% |
| April 18, 2024 | 218.0% |
| April 17, 2024 | 222.1% |
| April 16, 2024 | 245.3% |
| April 15, 2024 | 254.2% |
| April 12, 2024 | 274.5% |
| Date | Value |
|---|---|
| April 11, 2024 | 259.5% |
| April 10, 2024 | 230.3% |
| April 09, 2024 | 198.3% |
| April 08, 2024 | 187.9% |
| April 05, 2024 | 187.9% |
| April 04, 2024 | 203.6% |
| April 03, 2024 | 194.0% |
| April 02, 2024 | 196.4% |
| April 01, 2024 | 211.5% |
| March 28, 2024 | 234.7% |
| March 27, 2024 | 227.5% |
| March 26, 2024 | 237.7% |
| March 25, 2024 | 235.0% |
| March 22, 2024 | 248.6% |
| March 21, 2024 | 245.6% |
| March 20, 2024 | 234.4% |
| March 19, 2024 | 223.8% |
| March 18, 2024 | 225.3% |
| March 15, 2024 | 193.3% |
| March 14, 2024 | 163.0% |
| March 13, 2024 | 190.1% |
| March 12, 2024 | 175.6% |
| March 11, 2024 | 183.7% |
| March 08, 2024 | 152.3% |
| March 07, 2024 | 150.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.27%
Minimum
Aug 31 2022
331.9%
Maximum
May 03 2024
7.14%
Average
-22.13%
Median
Sep 27 2023
1 Year Total Returns (Daily) Benchmarks
| Viking Therapeutics Inc | 180.2% |
| Equillium Inc | 156.8% |
| Minerva Neurosciences Inc | -54.46% |
| Arvinas Inc | 37.69% |
| Calidi Biotherapeutics Inc | -97.66% |